NewsCuraleaf Enters Europe’s Largest Medical Cannabis Market Following EMMAC...

Curaleaf Enters Europe’s Largest Medical Cannabis Market Following EMMAC Move

-

FOLLOWING its recent acquisition of UK-firm EMMAC Life Sciences leading US player Curaleaf has wasted no time in expanding into Europe’s biggest medical cannabis market.

Curaleaf International (formerly EMMAC), through its wholly owned subsidiary Adven has launched its own range of medical cannabis products into Germany.  

It says the initial product launch of a high-THC oil product will be extended over the next few months to incorporate a number of different strengths and THC/CBD formulations in both oils and flower. 

Adven Managing Director Julian Vaterrodt said: “German patients and practitioners are increasingly demanding high-quality, consistent and reliable European natural alternatives to help manage a wide range of complaints.  

“Adven is committed to providing a differentiated product and service for the German market.”

Antonio Costanzo, CEO of Curaleaf International, added: “Curaleaf International’s European supply chain, from cultivation to product research and development and EU-GMP manufacturing processes across Europe, means we are able to guarantee a consistency of product and price to clinicians and patients in need of the highest quality medical cannabis.”

In its recent sixth European Cannabis Report Prohibition Partners estimates Germany had 128,000 active patients at the end of 2020. 

Its medical cannabis products are currently sourced from a wide range of countries including Canada, Netherlands, Uruguay, Portugal, Israel, Spain and Australia.

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

British People Open To Using Medical Cannabis – Yet Majority Unaware They Can Access It On Prescription 

A NEW national survey of 4,000 people has highlighted the need to improve awareness of cannabis as a medicine.  Key...

As US Hemp Cultivation Levels Plummet The Established European Industry Continues To Flourish 

DESPITE a huge decline in US hemp industry’s footprint the European industry will continue to grow, say the continent’s...

Chrystal Capital Acts As Exclusive Advisor To Change Agronomy On £9.6m Fundraise

CHRYSTAL Capital Partners LLP, is an entrepreneurial corporate finance and investment house with an established global network of Single...

European Cannabis Stocks Review: ‘End’ Of US Cannabis Bear Market Rallies European Stocks 

FOLLOWING last week’s rally there has seen something of a lull with little movement for European cannabis stocks. Last week’s...

Business of Cannabis Conference Returns to New York City on November 3rd

In this second summit, the most influential business leaders, investors and politicians gather to discuss social equity, policy and...

Curaleaf Takes Majority Stake And Forms Strategic Partnership With Germany’s Four 20 Pharma In €20m Deal

CURALEAF Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading U.S. provider of consumer products in cannabis, announced that Curaleaf International...

Must read

As US Hemp Cultivation Levels Plummet The Established European Industry Continues To Flourish 

DESPITE a huge decline in US hemp industry’s footprint...

European Cannabis Stocks Review: ‘End’ Of US Cannabis Bear Market Rallies European Stocks 

FOLLOWING last week’s rally there has seen something of...

You might also likeRELATED
Recommended to you